PharmaVOICE Recognizes Nextrials as a 2015 Innovator

Nextrials’ E2E integration tool for clinical researchers featured in a key roundup of innovative platforms serving the healthcare sector San Ramon, CA, May 12, 2015–Nextrials, Inc., a leader in clinical research software and services, has been recognized by Pharma VOICE for Prism®’s E2E™ electronic health record (EHR) integration tool. The magazine’s editors selected E2E for a list of the 16 most innovative platforms serving the health sector for 2015, citing its ability to integrate EHR systems with electronic data capture (EDC) for clinical research. By allowing researchers to extract data directly from EHRs, patient enrollment is easier, transcription errors are eliminated and data queries can be better managed within the platform – resulting in a quicker, more efficient system for taking novel therapeutics to market.

“Currently, the average length of time to develop a drug ranges from 10 to 15 years,” said Nextrials CEO Jim Rogers. “The costs associated with clinical trials are very steep, so delivering relevant patient data to researchers in a cleaner and faster manner saves money and speeds the decision making process. Integration with electronic health records is key to achieving these goals.”

Prism has now earned multiple industry awards, including the Society of Clinical Data Management’s Innovation Award, and offers pharmaceutical, biotech and medical device researchers an important step forward in achieving complete interoperability of their

systems. To learn more about Nextrials’E2E tool and the complete Prism platform, please click here.